Findings from this study suggest that oxaliplatin resistance in colon cancer cells involves the activation of SphK1/S1P/S1PR2 signaling axis that activates ERK signaling pathway resulting in the induction of CD44 expression [82]. This evidence concerns the gene MBTPS1 and colonic neoplasm.